Cwm, LLC Vertex Pharmaceuticals Inc Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cwm, LLC holds 6,414 shares of VRTX stock, worth $3.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,414

Previous 6,040 6.19%

Holding current value

$3.04 Million

Previous $2.53 Million 19.05%

% of portfolio

0.01%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$392.81 - $485.53 $146,910 - $181,588	374 Added 6.19%	6,414 $3.01 Million
Q1 2024 Apr 05, 2024	BUY	$407.69 - $446.08 $193,652 - $211,888	475 Added 8.54%	6,040 $2.53 Million
Q4 2023 Feb 01, 2024	BUY	$343.0 - $410.68 $65,170 - $78,029	190 Added 3.53%	5,565 $2.26 Million
Q3 2023 Oct 11, 2023	BUY	$338.18 - $362.46 $272,573 - $292,142	806 Added 17.64%	5,375 $1.87 Million
Q2 2023 Aug 03, 2023	BUY	$314.42 - $351.91 $107,217 - $120,001	341 Added 8.07%	4,569 $1.61 Million
Q1 2023 Apr 28, 2023	BUY	$283.23 - $323.1 $143,314 - $163,488	506 Added 13.59%	4,228 $1.33 Million
Q4 2022 Feb 01, 2023	BUY	$285.76 - $321.48 $70,296 - $79,084	246 Added 7.08%	3,722 $1.08 Million
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $80,506 - $89,825	294 Added 9.24%	3,476 $1.01 Million
Q2 2022 Jul 28, 2022	BUY	$234.96 - $292.55 $226,971 - $282,603	966 Added 43.59%	3,182 $897,000
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $219,870 - $259,143	993 Added 81.19%	2,216 $578,000
Q4 2021 Jan 31, 2022	BUY	$177.01 - $223.45 $96,470 - $121,780	545 Added 80.38%	1,223 $269,000
Q1 2021 Sep 15, 2021	SELL	$207.02 - $241.31 $414 - $482	-2 Reduced 0.29%	678 $137,000
Q1 2021 Apr 27, 2021	BUY	$207.02 - $241.31 $414 - $482	2 Added 0.29%	680 $146,000
Q4 2020 Sep 15, 2021	BUY	$207.01 - $276.09 $10,143 - $13,528	49 Added 7.79%	678 $137,000
Q4 2020 Jan 27, 2021	SELL	$207.01 - $276.09 $10,143 - $13,528	-49 Reduced 7.23%	629 $149,000
Q3 2020 Sep 15, 2021	BUY	$255.65 - $303.1 $73,882 - $87,595	289 Added 74.29%	678 $137,000
Q3 2020 Oct 19, 2020	SELL	$255.65 - $303.1 $73,882 - $87,595	-289 Reduced 42.63%	389 $106,000
Q2 2020 Sep 15, 2021	BUY	$225.48 - $295.8 $71,928 - $94,360	319 Added 88.86%	678 $137,000
Q2 2020 Jul 22, 2020	SELL	$225.48 - $295.8 $71,928 - $94,360	-319 Reduced 47.05%	359 $104,000
Q1 2020 Sep 15, 2021	BUY	$199.77 - $247.81 $65,125 - $80,786	326 Added 92.61%	678 $137,000
Q1 2020 Apr 28, 2020	SELL	$199.77 - $247.81 $65,125 - $80,786	-326 Reduced 48.08%	352 $84,000
Q4 2019 Sep 14, 2021	SELL	$166.71 - $223.91 $38,009 - $51,051	-228 Reduced 25.17%	678 $137,000
Q4 2019 Jan 27, 2020	BUY	$166.71 - $223.91 $38,009 - $51,051	228 Added 33.63%	906 $198,000
Q3 2019 Sep 14, 2021	BUY	$166.23 - $187.09 $65,328 - $73,526	393 Added 137.89%	678 $137,000
Q3 2019 Oct 22, 2019	SELL	$166.23 - $187.09 $65,328 - $73,526	-393 Reduced 57.96%	285 $48,000
Q2 2019 Sep 14, 2021	BUY	$164.61 - $190.37 $82,963 - $95,946	504 Added 289.66%	678 $137,000
Q2 2019 Jul 31, 2019	SELL	$164.61 - $190.37 $82,963 - $95,946	-504 Reduced 74.34%	174 $32,000
Q1 2019 Sep 02, 2021	BUY	$163.73 - $194.7 $84,648 - $100,659	517 Added 321.12%	678 $0
Q1 2019 Apr 22, 2019	SELL	$163.73 - $194.7 $1,309 - $1,557	-8 Reduced 4.73%	161 $30,000
Q4 2018 Jan 25, 2019	SELL	$151.91 - $192.21 $759 - $961	-5 Reduced 2.87%	169 $28,000
Q3 2018 Oct 29, 2018	BUY	$167.73 - $192.74 $2,348 - $2,698	14 Added 8.75%	174 $34,000
Q2 2018 Jul 31, 2018	SELL	$145.72 - $169.96 $5,683 - $6,628	-39 Reduced 19.6%	160 $27,000
Q1 2018 Apr 26, 2018	BUY	$151.6 - $177.13 $8,792 - $10,273	58 Added 41.13%	199 $32,000
Q4 2017 Jan 16, 2018	BUY	$137.28 - $155.55 $1,098 - $1,244	8 Added 6.02%	141 $21,000
Q3 2017 Oct 16, 2017	BUY	$148.13 - $162.24 $19,701 - $21,577	133	133 $20,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account